转诊中心感染性腹主动脉内移植物取出术经验
该单中心回顾性观察研究纳入2008年7月至2020年12月在波尔多大学医院因感染行腹主动脉内移植物取出的34例患者,依据MAGIC标准诊断,30天死亡率为21%(n=7),院内死亡率为27%(n=9),结论认为即使在高容量中心,完全取出感染内移植物后早期并发症和死亡率仍较高。
要点
- 34例患者中30天死亡率为21%(n=7),院内死亡率为27%(n=9)。
- 25例(73%)出现早期术后并发症,需16例(47%)再次手术。
- 中位随访16.2个月期间死亡率为35%(n=12),再感染2例(6%)。
核心结论
- 即使在高容量中心,完全取出感染性腹主动脉内移植物后早期并发症和死亡率仍较高。
- 作者认为,在大规模多中心队列中与其他治疗方式进行比较可能是有意义的。
研究设计与样本
- 单中心回顾性观察研究,纳入2008年7月至2020年12月在波尔多大学医院因感染行腹主动脉内移植物取出的患者。
- 共纳入34例患者,中位年龄69岁(四分位距[IQR] 65,76),其中4例(12%)作为急诊治疗。
- 诊断依据MAGIC标准。
- 主要终点为30天死亡率,次要终点为90天死亡率和院内死亡率、生存率及再感染。
主要发现
- 从EVAR到取出的中位时间为17.5个月(4.5-36.3)。
- 24例(71%)采用人工血管行原位重建,其中23例为结合银和三氯生的抗菌人工血管;10例采用生物移植物(5例股静脉、4例动脉同种异体移植物、3例牛心包补片、1例生物合成移植物)。
- 17例主动脉肠瘘(AEnF)中,10例(59%)行肠道直接修复,7例(41%)行切除吻合。
- 12例(35%)培养为多种微生物,4例(12%)培养无菌。
- 30天死亡率为21%(n=7),院内死亡率为27%(n=9)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The increasing use of endovascular aneurysm repair (EVAR) appears to be associated with the burden of vascular endograft infections. Complete stent graft explantation is recommended but leads to significant mortality. This study aimed to assess the technical challenges, complications, and mortality rate following infected endograft explantation. METHODS: Patients who underwent abdominal aortic endograft explantation for infection at the Bordeaux University Hospital from July 2008 to December 2020 were included retrospectively in this single centre observational study. The diagnosis was established based on the MAGIC criteria. The primary endpoint was 30 day mortality. Secondary endpoints were 90 day and in hospital mortality, survival, and re-infection. RESULTS: Thirty-four patients were included, median age 69 years (interquartile range [IQR] 65, 76), with four (12%) treated as an emergency. The median time from EVAR to explantation was 17.5 months (4.5 - 36.3). In situ reconstruction was carried out with prosthetic grafts in 24 patients (71%, including 23 antimicrobial grafts combining silver and triclosan), and biological grafts in 10 (five femoral veins, four arterial allografts, three bovine patches, one biosynthetic graft). Seventeen aorto-enteric fistulae (AEnF) were addressed with direct repair of the intestinal tract (n = 10/17; 59%) or resection and anastomosis (n = 7/17; 41%). The culture was polymicrobial in 12 patients (35%) and remained sterile in four (12%). The 30 day and in hospital mortality rates were 21% (n = 7) and 27% (n = 9). Twenty-five patients (73%) presented with early post-operative complications, requiring 16 revision procedures (47%). Over a median follow up of 16.2 months (IQR 8.3, 33.6), the mortality rate was 35% (n = 12; 11 aortic related; 32%), with two re-infections (6%), both after biological reconstruction (one for an AEnF). CONCLUSION: Early morbidity and mortality remain high after complete infected endograft explantation, even in a high volume centre. Comparison with other treatment modalities in large multicentre cohorts might be of interest.
引用
- Khalid W, Puges M, Stenson K, et al. Referral Centre Experience with Infected Abdominal Aortic Endograft Explantation. Eur J Vasc Endovasc Surg. 2022. PMID: 36209964. doi:10.1016/j.ejvs.2022.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。